MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-19-2026
Relmada Therapeutics P/B Ratio 2011-2026 | RLMD
Annual P/B Ratio Relmada Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.85 | 5.31 | 1.89 | 0.508 | 1.73 | 4.83 | 7.06 | -2.84 | 6.7 | 3.16 | 8.18 | -33.7 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.18 | -33.7 | 0.47 |
P/B Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
2.78 | - | 7.5 % | $ 6.35 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-27.6 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-18.8 | - | - | $ 754 M | USA |
 |
Harrow Health
HROW
|
37.1 | $ 34.79 | -0.97 % | $ 1.28 B | USA |
 |
Assertio Holdings
ASRT
|
0.802 | $ 18.84 | -2.18 % | $ 121 M | USA |
 |
Agile Therapeutics
AGRX
|
-0.0793 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
2.2 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
-0.473 | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
3.93 | $ 3.07 | -0.97 % | $ 43.2 M | USA |
 |
Cronos Group
CRON
|
2.12 | $ 2.54 | -1.55 % | $ 1.32 B |  Canada |
 |
Avadel Pharmaceuticals plc
AVDL
|
9.71 | - | - | $ 2.06 B |  France |
 |
OrganiGram Holdings
OGI
|
0.795 | $ 1.37 | -1.09 % | $ 402 M | Canada |
 |
Organogenesis Holdings
ORGO
|
1.08 | $ 2.29 | 2.01 % | $ 302 M | USA |
 |
Pacira BioSciences
PCRX
|
1.51 | $ 22.5 | 1.03 % | $ 1.04 B | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
0.662 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
0.122 | - | 2.45 % | $ 38.1 M | Canada |
 |
Sundial Growers
SNDL
|
0.000669 | $ 1.33 | -0.75 % | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
0.83 | $ 2.28 | -1.94 % | $ 2.83 M | USA |
 |
Bausch Health Companies
BHC
|
-41.3 | $ 5.23 | -3.42 % | $ 1.91 B | Canada |
 |
Tilray
TLRY
|
0.358 | $ 6.53 | -1.95 % | $ 4.04 B | Canada |
 |
Aurora Cannabis
ACB
|
0.449 | $ 3.39 | -1.46 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
0.291 | $ 0.99 | -3.08 % | $ 106 M | Canada |
 |
Veru
VERU
|
3.34 | $ 2.49 | 3.75 % | $ 336 M | USA |
 |
Viatris
VTRS
|
0.646 | $ 13.29 | -0.93 % | $ 16 B | USA |
 |
Catalent
CTLT
|
3.01 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
0.703 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.46 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
0.0133 | - | - | $ 28.9 M |  Irlanda |
 |
Evolus
EOLS
|
-11.7 | $ 4.08 | -1.9 % | $ 263 M | USA |
 |
Emergent BioSolutions
EBS
|
0.214 | $ 7.8 | -3.7 % | $ 399 M | USA |
 |
Evoke Pharma
EVOK
|
-0.868 | - | - | $ 36.6 M | USA |
 |
Jupiter Wellness
JUPW
|
-1.09 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-1.43 | - | 1.15 % | $ 7.11 M | USA |
 |
cbdMD
YCBD
|
0.857 | $ 0.71 | -2.75 % | $ 3.06 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
0.00923 | - | - | $ 193 M | Canada |
 |
OptiNose
OPTN
|
-2.21 | - | - | $ 1.08 B | USA |
 |
PetIQ
PETQ
|
0.456 | - | 1.64 % | $ 400 M | USA |
 |
PLx Pharma
PLXP
|
2.29 | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
2.05 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-1.5 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
2.27 | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
0.914 | $ 0.93 | -3.52 % | $ 33.5 M | USA |
 |
SCYNEXIS
SCYX
|
0.769 | $ 0.95 | 3.08 % | $ 47.4 M | USA |
 |
Solid Biosciences
SLDB
|
3.46 | $ 7.61 | -1.74 % | $ 666 M | USA |
 |
Zomedica Corp.
ZOM
|
0.572 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.406 | - | - | $ 55.5 M | USA |
 |
Tricida
TCDA
|
1.65 K | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
0.121 | $ 0.62 | 1.06 % | $ 2.66 M |  China |
 |
TherapeuticsMD
TXMD
|
0.857 | $ 2.05 | -6.72 % | $ 23.7 M | USA |